Bladder Cancer Markers, Urine

Bladder Cancer Markers, Urine is a topic covered in the Davis's Lab & Diagnostic Tests.

To view the entire topic, please or purchase a subscription.

Nursing Central is the award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:

Nursing Central

-- The first section of this topic is shown below --


Nuclear matrix protein (NMP) 22, BTA, cytogenic marker for bladder cancer.

Common Use:
To assist in diagnosing bladder cancer.

Urine, unpreserved random specimen collected in a clean plastic collection container for NMP22 and Bard BTA; urine, first void specimen collected in fixative specific for fluorescence in situ hybridization (FISH) testing.

Normal Findings:
(Method: Enzyme immunoassay for NMP22 and bladder tumor antigen [BTA], FISH for cytogenic marker).

NMP22: Negative: Less than 6 units/mL, borderline: 6 to 10 units/mL, positive: greater than 10 units/mL.

BTA: Negative.

Cytogenic Marker: Negative.

-- To view the remaining sections of this topic, please or purchase a subscription --


* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Bladder Cancer Markers, Urine ID - 425069 A1 - Bladh,Mickey Lynn, AU - Van Leeuwen,Anne M, BT - Davis's Laboratory & Diagnostic Tests UR - PB - F.A. Davis Company ET - 7 DB - Nursing Central DP - Unbound Medicine ER -